In-vitro Toxicology Testing Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Technology, Method, Application, End User, and Geography.

Market Snapshot

In-Vitro Toxicology Testing Market
Study Period:


Base Year:


Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The in-vitro toxicology testing market is expected to witness a CAGR of 7.1% during the forecast period. Factors that are driving market growth include the opposition to the use of animals in pre-clinical research, significant advancements in-vitro toxicology assays, and growing awareness regarding drug product safety.

In-vitro tests provide toxicity information in a cost-effective and timesaving manner. It is anticipated that rapid advances in biomedical sciences will result in the development of newer and advanced in-vitro test strategies for hazard characterization. Toxicity testing is slowly becoming proficient with various advanced technologies aiding the process. It is currently poised to take advantage of promising revolutions from the field of biotechnology. The applications of toxicity testing are set to increase with advances in biotechnology, resulting in a demand for the same in the market. The advances in toxicity testing practices, such as bioinformatics, computational toxicology, epigenetics, etc., hold the potential for a paradigm shift from whole-animal testing to in-vitro methods that evaluate changes in various processes, which use cell lines and other cellular components. A number of emerging fields and techniques are contributing major new insights for understanding biologic responses to chemicals in human tissues. These advances are expected to drive the growth of the in-vitro toxicology market during the forecast period.

However, the screening process is quite stringent for the approval of any healthcare molecule. Many molecules fail in the toxicity study stage and are barred from entering the market. In-vitro toxicology testing as an alternative to animal testing is by default always under the lens, as it is intended to replace a fully approved method for toxicity study (animal testing). This is because in-vitro toxicology testing has to match closely to the standards from in-vivo animal testing. Regulators, including the United States Food and Drug Administration (FDA), have issued guidance with regard to in-vitro studies to be conducted during drug development. However, current regulatory guidance does not address specific study designs for in-vitro toxicity testing. The experimental procedures and documentation of data for in-vitro testing should be rigorous, reproducible, with specific analytical methods, along with documentation of assay procedures and results. Therefore, these stringent regulations are restraining the growth of the in-vitro toxicology testing market, globally. Other factors, such as incapability of in-vitro models to determine autoimmunity and immunostimulation, are also acting as major restraints for the market studied.


Scope of the Report

In-vitro toxicity testing is referred to the method of scientifically analyzing the effects of lethal or toxic chemical materials either on mammalian cells or on cultured bacteria. In-vitro testing methods are performed mainly for the purpose of identifying potentially harmful chemicals and/or for confirming the deficiency of certain toxic properties in the initial stages of the development of possibly useful novel substances, including therapeutic drugs, agricultural chemicals, and even food additives.

By Technology
Cell Culture
High Throughput
Molecular Imaging
By Method
Cellular Assay
Biochemical Assay
In Silica
By Application
Systemic Toxicology
Dermal Toxicity
Endorine Disruption
Occular Toxicity
Other Applications
By End User
Pharmaceutical Industry
Cosmetics & Household Products
Chemicals Industry
Food Industry
North America
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cell Culture is Expected to Hold Significant Market Share in the Technology Type

Recent inventions and advances in human cell culture exposure, as well as test systems, have allowed the expansion and development of in-vitro assay systems, which are predictive, demonstrative and suitable for toxicity screening of a varied range of chemicals including nanomaterials and airborne materials. In-vitro toxicology involves using cells or tissues grown or maintained in a controlled laboratory environment to examine the toxic properties of various compounds and mixtures. This further enables one to examine the toxicity of xenobiotics at the basic level of the cell without involving the interplay of complex physiological systemic effects, which are often observed in entire organisms. However, definite cellular functions could be studied with primary cell cultures obtained from specific tissues such as the kidney or gills for ionic homeostasis, liver for xenobiotic biotransformation, and the nerve cells for neurotransmitter signaling effects.

In-Vitro Toxicology Testing Market

To understand key trends, Download Sample Report

North America Dominates the Market and is Expected to Do So in the Forecast Period

Over the past few years, technical advancements and supportive government regulations have led to the rapid development of innovative, cost-effective testing for establishing drug, device, chemical and cosmetic safety, in North America. The significant increase in investment in instruments and the ongoing expansion of laboratory capabilities, across the region, currently, enable clients to establish toxicological profiles of medical devices, biopharmaceuticals, cosmetics, and chemicals. These investments include an expansion of the existing cell/tissue culture capabilities, flow cytometry, and mass spectrometry facilities, apart from the introduction of high throughput screening, automation, and multiplexing technologies for biomarker analysis.

In-Vitro Toxicology Testing Market

To understand geography trends, Download Sample Report

Competitive Landscape

The in-vitro toxicology testing market is highly competitive and consists of a few major players. Companies, such as Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Covance, Eurofins Scientific, GE Healthcare, Merck KGaA, Promega Corporation, Quest Diagnostics, and Thermo Fisher Scientific, among others, hold a substantial market share in the market studied.

Major Players

  1. Abbott Laboratories
  2. Agilent Technologies
  3. Bio-Rad Laboratories
  4. Covance
  5. Eurofins Scientific

* Complete list of players covered available in the table of contents below

In-Vitro Toxicology Testing Market

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Opposition to the Usage of Animals in Pre-clinical Research

      2. 4.2.2 Significant Advancements In-vitro Toxicology Assays

      3. 4.2.3 Increasing Awareness Regarding Drug Product Safety

    3. 4.3 Market Restraints

      1. 4.3.1 Incapability of In-vitro Models to Determine Autoimmunity and Immunostimulation

      2. 4.3.2 Stringent Regulatory Framework for the In-vitro Tests

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Technology

      1. 5.1.1 Cell Culture

      2. 5.1.2 High Throughput

      3. 5.1.3 Molecular Imaging

      4. 5.1.4 OMICS

    2. 5.2 By Method

      1. 5.2.1 Cellular Assay

      2. 5.2.2 Biochemical Assay

      3. 5.2.3 In Silica

      4. 5.2.4 Ex-vivo

    3. 5.3 By Application

      1. 5.3.1 Systemic Toxicology

      2. 5.3.2 Dermal Toxicity

      3. 5.3.3 Endorine Disruption

      4. 5.3.4 Occular Toxicity

      5. 5.3.5 Other Applications

    4. 5.4 By End User

      1. 5.4.1 Pharmaceutical Industry

      2. 5.4.2 Cosmetics & Household Products

      3. 5.4.3 Diagnostics

      4. 5.4.4 Chemicals Industry

      5. 5.4.5 Food Industry

    5. 5.5 Geography

      1. 5.5.1 North America

        1. US

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. UK

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies

      3. 6.1.3 Bio-Rad Laboratories

      4. 6.1.4 Covance

      5. 6.1.5 Eurofins Scientific

      6. 6.1.6 GE Healthcare

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Promega Corporation

      9. 6.1.9 Quest Diagnostics

      10. 6.1.10 Thermo Fisher Scientific

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!

Complete your payment details below

Shipping & Billing Information

Payment Information